Development of a diagnostic test (ELISA) to detect antibodies against tumour antigen NY-ESO-1 (Q3313607): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
(‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
label / frlabel / fr
 
Mise au point d’un test de diagnostic (ELISA) pour la détection d’anticorps contre l’antigène tumoral NY-ESO-1
Property / summary
 
Mise au point d’un test de diagnostic (ELISA) pour la détection d’anticorps contre l’antigène tumoral NY-ESO-1 (French)
Property / summary: Mise au point d’un test de diagnostic (ELISA) pour la détection d’anticorps contre l’antigène tumoral NY-ESO-1 (French) / rank
 
Normal rank
Property / summary: Mise au point d’un test de diagnostic (ELISA) pour la détection d’anticorps contre l’antigène tumoral NY-ESO-1 (French) / qualifier
 
point in time: 6 December 2021
Timestamp+2021-12-06T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 16:02, 6 December 2021

Project Q3313607 in Germany
Language Label Description Also known as
English
Development of a diagnostic test (ELISA) to detect antibodies against tumour antigen NY-ESO-1
Project Q3313607 in Germany

    Statements

    0 references
    0 references
    347,150.02 Euro
    0 references
    433,937.52 Euro
    0 references
    80.0 percent
    0 references
    11 January 2018
    0 references
    30 April 2021
    0 references
    Adversis Pharma GmbH
    0 references
    0 references
    0 references

    51°20'26.27"N, 12°22'29.03"E
    0 references
    Entwicklung eines diagnostischen Tests (ELISA) zum Nachweis von Antikörpern gegen das Tumorantigen NY-ESO-1 (German)
    0 references
    Development of a diagnostic test (ELISA) to detect antibodies against tumour antigen NY-ESO-1 (English)
    25 October 2021
    0 references
    Mise au point d’un test de diagnostic (ELISA) pour la détection d’anticorps contre l’antigène tumoral NY-ESO-1 (French)
    6 December 2021
    0 references
    Leipzig, Stadt
    0 references

    Identifiers

    672 / 101003528841
    0 references